A case report of cerebral vasculitis induced by ipilimumab with nivolumab in a patient with metastatic renal cell carcinoma

The prognosis of patients with metastatic renal cell carcinoma (RCC) has improved with the introduction of novel combination therapies, including monoclonal antibodies such as ipilimumab (against CTLA-4) with nivolumab (against PD-1). However, these checkpoint inhibitors are associated with a broad...

Description complète

Détails bibliographiques

Auteurs principaux:	Patrik Palacka, Tomáš Málek, Marek Makovník, Renáta Felediová, Boris Rychlý, Georgína Kolníková
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2026-03-01
Collection:	Frontiers in Immunology
Sujets:	cerebral vasculitis metastatic renal cell carcinoma non-clear-cell carcinoma ipilimumab nivolumab
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1779015/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!